Rigel Pharmaceuticals Investors

Rigel Pharmaceuticals is a venture capital fund based in South San Francisco, California, established in 1996 The firm specializes in investing in innovative biotechnology companies that are focused on developing novel therapeutic solutions Rigel Pharmaceuticals manages an investment scale of approximately $35,000,000, targeting early to mid-stage ventures in the life sciences sector The funds strategic focus is on fostering advancements that can significantly impact patient care and treatment outcomes

Estimated Revenue: $10M to $50M
Funding Status: IPO
Investor Type: Venture Capital Funds
Employee Number: 101-250
Industry: FemTech
Headquarters: USA
Founded Date: 1996
Technology: Metabolic Disorders